MRNA: Timeline of Clinical Trials; Operation Warp Speed
This is a timeline of funding related to the US Government's Operation Warp Speed. MRNA and NVAX are the two stocks that have reacted strongly (in both directions) to any kind of COVID news. You can see that towards the end of phase 1 trials, they disclosed grade 3 adverse reactions to the vaccine which led to a -50% drop in the stock.
Note
MRNA is currently a buy based on histogram.
Note
Used a different indicator to confirm the buy signal. So, yes; I am confident that this will be a good trade for longs.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.